170 related articles for article (PubMed ID: 36145666)
1. SmartFilm Tablets for Improved Oral Delivery of Poorly Soluble Drugs.
Abdelkader A; Preis E; Keck CM
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145666
[TBL] [Abstract][Full Text] [Related]
2. Improving the Bioactivity of Norfloxacin with Tablets Made from Paper.
Abdelkader A; Nallbati L; Keck CM
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839695
[TBL] [Abstract][Full Text] [Related]
3. Tablets Made from Paper-An Industrially Feasible Approach.
Abdelkader A; Moos C; Pelloux A; Pfeiffer M; Alter C; Kolling S; Keck CM
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297300
[TBL] [Abstract][Full Text] [Related]
4. Terahertz-spectroscopy for non-destructive determination of crystallinity of L-tartaric acid in smartFilms® and tablets made from paper.
Ornik J; Knoth D; Koch M; Keck CM
Int J Pharm; 2020 May; 581():119253. PubMed ID: 32217156
[TBL] [Abstract][Full Text] [Related]
5. Improved Dermal and Transdermal Delivery of Curcumin with SmartFilms and Nanocrystals.
Eckert RW; Wiemann S; Keck CM
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804137
[TBL] [Abstract][Full Text] [Related]
6. pH - Responsive colloidal carriers assembled from β-lactoglobulin and Epsilon poly-L-lysine for oral drug delivery.
Pujara N; Giri R; Wong KY; Qu Z; Rewatkar P; Moniruzzaman M; Begun J; Ross BP; McGuckin M; Popat A
J Colloid Interface Sci; 2021 May; 589():45-55. PubMed ID: 33450459
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid.
Piao ZZ; Choe JS; Oh KT; Rhee YS; Lee BJ
Eur J Pharm Sci; 2014 Jan; 51():67-74. PubMed ID: 24012590
[TBL] [Abstract][Full Text] [Related]
8. Polyvinylpyrrolidone as co-inhibitor of crystallization of nifedipine in paper tablets.
Heidrich L; Ornik J; Keck CM; Castro-Camus E; Koch M
Int J Pharm; 2023 Mar; 635():122721. PubMed ID: 36781082
[TBL] [Abstract][Full Text] [Related]
9. Effect of hydrogen bond formation/replacement on solubility characteristics, gastric permeation and pharmacokinetics of curcumin by application of powder solution technology.
Sharma V; Pathak K
Acta Pharm Sin B; 2016 Nov; 6(6):600-613. PubMed ID: 27818928
[TBL] [Abstract][Full Text] [Related]
10. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment.
Usta DY; Timur B; Teksin ZS
Eur J Pharm Sci; 2022 Jul; 174():106159. PubMed ID: 35263632
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
Jantratid E; Prakongpan S; Amidon GL; Dressman JB
Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
Ramadhani N; Shabir M; McConville C
Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of polymeric micelle containing tablet formulation for poorly water-soluble drug: tamoxifen citrate.
Öztürk-Atar K; Kaplan M; Çalış S
Drug Dev Ind Pharm; 2020 Oct; 46(10):1695-1704. PubMed ID: 32893676
[TBL] [Abstract][Full Text] [Related]
14. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
15. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.
Cappello B; De Rosa G; Giannini L; La Rotonda MI; Mensitieri G; Miro A; Quaglia F; Russo R
Int J Pharm; 2006 Aug; 319(1-2):63-70. PubMed ID: 16650700
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
[TBL] [Abstract][Full Text] [Related]
18. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine.
Wang R; Han J; Jiang A; Huang R; Fu T; Wang L; Zheng Q; Li W; Li J
Int J Pharm; 2019 Apr; 561():9-18. PubMed ID: 30817985
[TBL] [Abstract][Full Text] [Related]
19. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
[TBL] [Abstract][Full Text] [Related]
20. Three dimensional macroporous hydroxyapatite/chitosan foam-supported polymer micelles for enhanced oral delivery of poorly soluble drugs.
Zhang Y; Dong K; Wang F; Wang H; Wang J; Jiang Z; Diao S
Colloids Surf B Biointerfaces; 2018 Oct; 170():497-504. PubMed ID: 29960950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
